There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Xtant Medical Holdings (XTNT – Research Report), Apollo Medical Holdings (AMEH – Research Report) and Atricure (ATRC – Research Report) with bullish sentiments.
Xtant Medical Holdings (XTNT)
BTIG analyst Ryan Zimmerman maintained a Buy rating on Xtant Medical Holdings on January 5 and set a price target of $2.00. The company’s shares closed last Friday at $1.19.
According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of
Xtant Medical Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $1.93.
See Insiders’ Hot Stocks on TipRanks >>
Apollo Medical Holdings (AMEH)
In a report issued on January 5, David Larsen from BTIG maintained a Buy rating on Apollo Medical Holdings, with a price target of $45.00. The company’s shares closed last Friday at $36.81.
According to TipRanks.com, Larsen has 0 stars on 0-5 stars ranking scale with an average return of
Apollo Medical Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $47.50.
Atricure (ATRC)
BTIG analyst Marie Thibault maintained a Buy rating on Atricure on January 5 and set a price target of $65.00. The company’s shares closed last Friday at $33.03, close to its 52-week low of $32.17.
According to TipRanks.com, Thibault is a 1-star analyst with an average return of
Atricure has an analyst consensus of Strong Buy, with a price target consensus of $54.86, a 68.7% upside from current levels. In a report issued on December 21, Canaccord Genuity also maintained a Buy rating on the stock with a $50.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on XTNT:
